Improvement of Understanding of Pediatric Sacral Neuromodulation: Therapeutic Strategies and Outcome Variables
Recruiting
N/A
Interventional Study
Gastrointestinal Motility Disorders in Children
Hirschsprung Disease
Constipation - Functional
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 3 – 18
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 25 (estimated)
- Sponsor
- Friedrich-Alexander-Universität Erlangen-Nürnberg · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this study is to learn about the effects of sacral neuromodulation in pediatric patients with gastrointestinal motility disorders. By combining advanced neuroimaging, patient-specific biophysical modeling, electrophysiological characterization, and clinical translation, the SMART-GUT project establishes a comprehensive framework to systematically investigate neuromodulation in this ped…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* informed consent of patient and care taker
* gastrointestinal motility disorder, disregarding underlying diseases
* exclusion of mechanical obstructions in the gastrointestinal passage
* age between 3 and 18
Exclusion Criteria:
* pregnancy/breast feeding
* decreased renal or…
Contacts